Johnson & Johnson said Monday it would pay $480 million for medical device maker Micrus Endovascular, adding a range of treatments for stroke and brain aneurysms.
The deal is expected to close during the second half of 2010.
Micrus, based in San Jose, Calif., focuses on devices aimed at treating stroke and aneurysms. Revenue reached $91.1 million in the fiscal year ended in March.
Most of Micrus' products to treat and prevent nonembolic strokes are manufactured in Miramar, where the company has an undisclosed number of administrative, manufacturing, research and development employees.
Latest from Today's Medical Developments
- GrindingHub Americas launches in 2027 in Cincinnati, Ohio
- Methods Machine Tools now offers the Nakamura-Tome NT-Flex
- Battelle awards $900,000 in STEM education grants to Ohio schools
- #55 Lunch + Learn Podcast with KINEXON
- Starrett and Gerstner offer limited edition, American made 1950s replica wooden machinist tool chests
- EMCO’s UNIVERSALTURN 50: The new benchmark in universal turning
- Archetype's Expertise for Equity accelerates early-stage innovation
- Stratasys expands its AM solutions with Tritone's cutting-edge technology
